OTC Markets OTCPK - Delayed Quote USD
Futura Medical plc (FAMDF)
0.0300
0.0000
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. James Henry Barder | CEO & Executive Director | 622.8k | -- | 1959 |
| Ms. Angela Hildreth | COO, Finance Director, Company Secretary & Executive Director | 497.1k | -- | 1980 |
| Mr. Kenneth William James | Head of R&D & Executive Director | 456.27k | -- | 1952 |
| Dr. William Duncan Potter | Chief Scientific Officer & Adviser to the Board | -- | 190.66k | 1948 |
| Graham Smith | Head of Alliance Partnerships & Supply | -- | -- | -- |
| Kevin Langridge | Head of Quality | -- | -- | -- |
Futura Medical plc
Surrey Technology Centre
40 Occam Road
Guildford, GU2 7YG
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 14
Description
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Corporate Governance
Futura Medical plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 15, 2025 at 6:00 AM UTC
Futura Medical plc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
BXPHF Botanix Pharmaceuticals Limited
0.2300
0.00%
SRBCF Sirona Biochem Corp.
0.0186
0.00%
PXMD PaxMedica, Inc.
0.0001
0.00%
IMRN Immuron Limited
1.7205
-2.80%
OABI OmniAb, Inc.
1.8200
-1.62%
CAMP CAMP4 THERAPEUTICS CORPORATION
1.9900
+0.51%
ORIC ORIC Pharmaceuticals, Inc.
5.19
+0.39%
VRAX Virax Biolabs Group Limited
1.0900
+4.81%
LEXX Lexaria Bioscience Corp.
1.6900
+6.29%